Immunology and Allergy papers
Pofolia’s corpus holds 87 papers from Immunology and Allergy (2012–2026), each with a short summary. Below, the 20 most-cited, then the most recently added.
At a glance
- Most cited: The extracellular matrix: A dynamic niche in cancer progression (2012, 3,025 citations).
- The 20 papers listed have 22,642 citations between them.
- 19 of the 20 with a known journal quartile appeared in a Q1 journal.
- 13 have a free full text (open access).
- Most frequent journals: Allergy, New England Journal of Medicine, Signal Transduction and Targeted Therapy.
- Published between 2012 and 2023.
Most cited
Ranked by citation count. Because citations accumulate over time, this list naturally leans towards work published a few years ago; for where the field is now, see “recently added”. How to read the signals
The extracellular matrix: A dynamic niche in cancer progression
The Journal of Cell Biology · 2012 · Q1 · SJR 3.00 · FWCI 82.10 · 3,025 citations · Open access
The extracellular matrix (ECM), a key component of the cancer microenvironment, is deregulated in cancer and actively promotes tumor progression and metastasis.
Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy
New England Journal of Medicine · 2015 · Q1 · SJR 18.00 · FWCI 143.81 · 2,217 citations · Open access
Introducing peanuts early to high-risk infants significantly reduced the development of peanut allergy by age 5, with a 1.9% allergy rate in the consumption group versus 13.7% in the avoidance group for those with no initial sensitivity.
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
Allergy · 2014 · Q1 · SJR 3.00 · FWCI 56.94 · 1,364 citations
These evidence-based guidelines from the European Academy of Allergy and Clinical Immunology provide updated recommendations for the diagnosis and management of food allergy.
Targeting integrin pathways: mechanisms and advances in therapy
Signal Transduction and Targeted Therapy · 2023 · Q1 · SJR 17.00 · FWCI 184.96 · 1,215 citations · Open access
Integrins, crucial cell-adhesion receptors, are complex therapeutic targets with only seven drugs successfully marketed despite 40 years of research. However, approximately 90 new integrin-based therapies are currently in clinical studies.
World Allergy Organization Anaphylaxis Guidance 2020
World Allergy Organization Journal · 2020 · Q1 · SJR 1.00 · FWCI 71.32 · 1,109 citations · Open access
The World Allergy Organization (WAO) has updated its 2011 anaphylaxis guidelines, reaffirming intramuscular epinephrine as the first-line treatment while noting its suboptimal use.
Notch signaling pathway: architecture, disease, and therapeutics
Signal Transduction and Targeted Therapy · 2022 · Q1 · SJR 17.00 · FWCI 121.58 · 1,068 citations · Open access
The Notch signaling pathway, identified over a century ago, plays a dual role in cancer, capable of both promoting and inhibiting tumor development, with its targeted therapies thus far failing to meet expectations.
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology
Allergy · 2014 · Q1 · SJR 3.00 · FWCI 51.79 · 1,053 citations · Open access
New guidelines from the European Academy of Allergy and Clinical Immunology (EAACI) provide evidence-based recommendations for recognizing, assessing risk, and managing anaphylaxis, a potentially life-threatening emergency.
Prevalence and Severity of Food Allergies Among US Adults
JAMA Network Open · 2019 · Q1 · SJR 3.00 · FWCI 65.22 · 1,011 citations
An estimated 10.8% of US adults, over 26 million people, have a confirmed food allergy, with shellfish, milk, and peanut being the most common. Nearly half of these individuals experienced a severe reaction, and almost half are allergic to multiple foods.
ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis
Journal of Leukocyte Biology · 2020 · Q2 · SJR 1.00 · FWCI 47.17 · 966 citations
ICAM-1, a cell surface receptor, is newly recognized not only for its role in leukocyte recruitment during inflammation but also as a master regulator of epithelial injury resolution and immune cell function in tumorigenesis.
RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
Molecular Pharmaceutics · 2012 · Q1 · FWCI 26.95 · 943 citations
RGD peptides can selectively bind to the alpha(v)beta(3) integrin, a key molecule in tumor angiogenesis and expressed on tumor cells. This review highlights RGD-based strategies, particularly nanoparticles, for targeted cancer therapy and diagnosis.
Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments
Molecular Cancer · 2023 · Q1 · SJR 9.00 · FWCI 138.42 · 913 citations · Open access
The extracellular matrix (ECM) actively drives tumor progression and immune evasion by altering its composition, stiffness, and mechanical properties, creating a suppressive microenvironment that hinders cancer treatments.
EAACI Molecular Allergology User's Guide
Pediatric Allergy and Immunology · 2016 · Q1 · SJR 1.00 · FWCI 58.95 · 913 citations · Open access
The EAACI Molecular Allergology User's Guide (MAUG) consolidates current knowledge on allergen molecules and component-resolved diagnosis (CRD) for IgE-mediated allergies.
The skin prick test – European standards
Clinical and Translational Allergy · 2013 · Q1 · SJR 1.00 · FWCI 26.28 · 896 citations · Open access
European standards for skin prick testing are proposed, defining a positive result as a wheal ≥3 mm diameter after 15-20 minutes and recommending a standard panel of 20 common inhalant allergens.
Allergic rhinitis
Nature Reviews Disease Primers · 2020 · Q1 · SJR 15.00 · FWCI 43.79 · 896 citations · Open access
Allergen immunotherapy, when administered by specialists using high-quality extracts in carefully selected patients, proves effective for persistent allergic rhinitis symptoms.
Prevalence of common food allergies in Europe: a systematic review and meta-analysis
Allergy · 2014 · Q1 · SJR 3.00 · FWCI 16.65 · 886 citations
This meta-analysis provides the most up-to-date prevalence estimates for common food allergies in Europe, finding self-reported lifetime prevalence ranging from 0.1% to 6.0% across different allergens.
Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants
New England Journal of Medicine · 2016 · Q1 · SJR 18.00 · FWCI 74.69 · 880 citations · Open access
Early introduction of six allergenic foods (peanut, egg, milk, sesame, fish, wheat) to breast-fed infants did not significantly reduce food allergy rates in an intention-to-treat analysis, but did show benefits in a per-protocol analysis.
The Public Health Impact of Parent-Reported Childhood Food Allergies in the United States
PEDIATRICS · 2018 · Q1 · SJR 2.00 · FWCI 40.99 · 878 citations · Open access
An estimated 7.6% of US children have current food allergies, with peanut, milk, and shellfish being the most common, impacting public health significantly.
TGF-β Activation and Function in Immunity
Annual Review of Immunology · 2013 · Q1 · SJR 16.00 · FWCI 20.09 · 832 citations
Transforming growth factor-beta (TGF-β) is a critical regulator of immune responses, with its activation state determining whether it dampens or promotes T cell activity.
Biology of the Extracellular Matrix
Journal of Glaucoma · 2014 · Q1 · FWCI 2.52 · 797 citations
The extracellular matrix (ECM) is a complex, dynamic network of macromolecules that provides structural integrity to tissues and regulates fundamental cellular behaviors.
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis
Allergy · 2017 · Q1 · SJR 3.00 · FWCI 35.36 · 780 citations · Open access
New EAACI guidelines recommend allergen immunotherapy (AIT) for allergic rhinoconjunctivitis (AR) due to its disease-modifying potential, offering a treatment that targets underlying pathophysiology beyond symptom management.
Recently added
Multiple bee stings leading to a delayed fatal coronary event with probable Kounis syndrome: a case report
International Journal of Emergency Medicine · 2026 · Q2
A 72-year-old man experienced a fatal coronary event approximately 13 hours after multiple bee stings, presenting as a probable delayed Type II Kounis syndrome, a condition where allergic reactions trigger acute coronary syndromes.
The “Five in One” integrated precise prevention and control system for pollen allergic diseases in Northern China: A narrative review with global perspective
Asia Pacific Allergy · 2026 · Q2
Northern China developed a "Five in One" system combining pollen monitoring, vegetation survey, epidemiology, primary-care training, and public education to combat rising pollen allergies.
Discovery of Long-Acting Bifunctional Compounds with Muscarinic M3 and Histamine H1 Receptor Antagonism for the Treatment of Rhinitis
Journal of Medicinal Chemistry · 2026 · Q1 · SJR 1.00
New heterobifunctional compounds simultaneously block muscarinic M3 and histamine H1 receptors, offering a potential once-daily intranasal treatment for refractory rhinitis with prolonged nasal residence (>24 h) and negligible systemic exposure.
Allergic rhinitis in primary care: Navigating diagnostic uncertainty, treatment failure and referral
npj Primary Care Respiratory Medicine · 2026 · Q1 · SJR 1.00
Primary care clinicians can use a decision sequence to manage allergic rhinitis, distinguishing clinically relevant allergy from other conditions and optimizing treatment and referral to reduce unnecessary testing and delays.
Biomarkers for successful allergen immunotherapy: are we there yet?
Current Opinion in Allergy and Clinical Immunology · 2026 · Q2
No single biomarker or combination currently predicts clinical response or sustained benefit for allergen immunotherapy (AIT), despite AIT inducing reproducible immune changes.
Innovative positioning of respiratory allergen immunotherapy: a focus on precision medicine
Expert Opinion on Biological Therapy · 2026 · Q1 · SJR 1.00
Allergen immunotherapy (AIT) is shifting from empirical personalization to a structured, precision-medicine framework using molecular diagnostics and digital health tools to optimize patient selection and treatment strategies.
Real-World Safety and Effectiveness of Adalimumab in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis: A Post-Marketing Surveillance Study in Korea
Ocular Immunology and Inflammation · 2026 · Q2
Adalimumab treatment in Korean patients with non-infectious intermediate, posterior, or panuveitis (NIIPPU) showed an acceptable safety profile and potential effectiveness, with a significant decrease in corticosteroid use and improvement in inflammation markers.
Early-Life Nutrition: The Interplay of Nutritional, Microbial, Genetic, and Environmental Factors in Food Allergy Development and Prevention
Nutrients · 2026 · Q1 · SJR 1.00
Introducing allergenic foods like peanut and egg during complementary feeding is the most consistent strategy for preventing food allergies, according to a review of current evidence.
Journals in this field
The journals that publish most of this field’s papers. Quartile (Q1–Q4), SJR and h-index are from SCImago Journal Rank; “in this field” is how many of the journal’s pooled papers belong here. What is a Q1 journal? · What is the h-index?
| Journal | Quartile | SJR | h-index | In this field | Summaries |
|---|---|---|---|---|---|
| Allergy: European Journal of Allergy and Clinical Immunology | Q1 | 3.00 | 226 | 9 | 15 |
| New England Journal of Medicine | Q1 | 18.00 | 1275 | 6 | 376 |
| World Allergy Organization Journal | Q1 | 1.00 | 67 | 5 | 5 |
| Journal of Allergy and Clinical Immunology | Q1 | 3.00 | 364 | 3 | 6 |
| Signal Transduction and Targeted Therapy | Q1 | 17.00 | 224 | 2 | 9 |
| Science | Q1 | 10.00 | 1433 | 2 | 268 |
| International Journal of Molecular Sciences | Q1 | 1.00 | 365 | 2 | 45 |
| Nutrients | Q1 | 1.00 | 279 | 2 | 25 |
Every journal in Immunology and Allergy (Q1–Q4) →
Add this field to your daily feed
Pick your interests and new work in your area arrives every day, summarised. Full summaries live in the app.
Open the app